L-Leucyl-L-Leucine Methyl Ester

N/A

Report date: 2023/08/28 20:00:45
NME

Base Information

Drug NameL-Leucyl-L-Leucine Methyl Ester
Drug Alias NameLeuLeuOMeLLME
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHematologic NeoplasmsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThomas Jefferson UniversityNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSidney Kimmel Cancer Center At Thomas Jefferson UniversityNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsHematologic NeoplasmsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A